PRESS RELEASE published on 05/15/2024 at 07:30, 1 year 8 months ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma annonce le succès de son offre globale de 19,2 millions d'euros pour financer ses activités de R&D en biotechnologie clinique avancée, incluant des essais cliniques et le développement de son portefeuille thérapeutique Essais Cliniques Offre Globale MaaT Pharma Biotechnologie Clinique Portefeuille Thérapeutique
BRIEF published on 05/14/2024 at 19:39, 1 year 9 months ago MaaT Pharma annonce une offre mondiale et des développements stratégiques de 18 millions d'euros Stratégie Financière Essai De Phase 3 Offre Globale Thérapies Écosystémiques Du Microbiome Biotechnologie Au Stade Clinique
BRIEF published on 05/14/2024 at 19:39, 1 year 9 months ago MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
PRESS RELEASE published on 05/14/2024 at 19:34, 1 year 9 months ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma lance une augmentation de capital de 18 millions d'euros pour financer ses activités de R&D, incluant des essais cliniques aux États-Unis et en Europe Actionnaires Augmentation De Capital R&D Essais Cliniques MaaT Pharma
PRESS RELEASE published on 05/14/2024 at 19:34, 1 year 9 months ago Inside Information / News release on accounts, results MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
Published on 02/14/2026 at 01:00, 1 day ago Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:15, 1 day 3 hours ago Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 7 hours ago Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 10 hours ago Datametrex Received $500,000 Purchase Order For Data Centre Solutions
Published on 02/14/2026 at 16:30, 8 hours 57 minutes ago Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 19 hours 22 minutes ago The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities
Published on 02/13/2026 at 19:20, 1 day 6 hours ago Retail offering successfully completed and update on Euronext Growth Oslo listing
Published on 02/13/2026 at 19:01, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/13/2026 at 18:20, 1 day 7 hours ago GLOBAL TECHNOLOGY LEADERS LAUNCH TRUSTED TECH ALLIANCE
Published on 02/13/2026 at 18:05, 1 day 7 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 7 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 7 hours ago Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 7 hours ago Nombre total d'actions et droits de vote - janvier 2026
